SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-061942
Filing Date
2024-07-17
Accepted
2024-07-17 08:30:32
Documents
15
Period of Report
2024-07-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209541-8k_longeveron.htm   iXBRL 8-K 27106
2 PRESS RELEASE ISSUED BY THE COMPANY ON JULY 17, 2024 ea020954101ex99-1_longeveron.htm EX-99.1 18878
6 GRAPHIC ex99-1_001.jpg GRAPHIC 3035
  Complete submission text file 0001213900-24-061942.txt   233180

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lgvn-20240717.xsd EX-101.SCH 3021
4 XBRL LABEL FILE lgvn-20240717_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lgvn-20240717_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209541-8k_longeveron_htm.xml XML 3782
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 241121020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)